Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial
Official title:
Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder
This study aims to investigate the effectiveness of an Internet-Assisted behavioral parent training intervention on children's ADHD symptoms and children's and parents' mental health status.
Status | Recruiting |
Enrollment | 118 |
Est. completion date | February 29, 2024 |
Est. primary completion date | February 29, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 12 Years |
Eligibility | Inclusion Criteria: - 1.Meeting the diagnostic criteria for ADHD in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition - 2.Total IQ greater than 70 as measured by the Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV) - 3.Child and their parents consent to the study Exclusion Criteria: - 1.Children or parents with severe organic encephalopathy and other severe mental disorders - 2.Has received or is receiving behavioral treatment (parent training) - 3.Parents who could not understand or lacking of access to computers and the Internet |
Country | Name | City | State |
---|---|---|---|
China | Wuhan Mental Health Centre | Wuhan | Hubei |
Lead Sponsor | Collaborator |
---|---|
Wuhan Mental Health Centre |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Chinese version of Swan-son Nolan and Pelham,Version IV Scale-parent form (SNAP-IV) | Measure of child Adhd-symptoms change from baseline to 2 months | From baseline to 2 months | |
Primary | Strengths & Difficulties Questionnaire(SDQ) | To measure child behavioral problems change from baseline to 2 months | From baseline to 2 months | |
Primary | Weiss Functional Im- pairment Rating Scales(WFIRS) | To measure child Social functioning change from baseline to 2 months | From baseline to 2 months | |
Secondary | Screen for Child Anxiety Related Emotional Disorders (SCARED) | To measure child anxiety symptoms change from baseline to 2 months | From baseline to 2 months | |
Secondary | Children's Depression Inventory-Short Form (CDI-S) | To measure child depression symptoms change from baseline to 2 months | From baseline to 2 months | |
Secondary | The seven-item version of the Generalized Anxiety Disorder (GAD-7) | To measure parental anxiety symptoms change from baseline to 2 months | From baseline to 2 months | |
Secondary | The nine-item version of the Patient Health Questionnaire (PHQ-9) | To measure parental depression symptoms change from baseline to 2 months | From baseline to 2 months | |
Secondary | Parenting Stress Index-Short Form (PSI-SF) | To measure parental parenting stress change from baseline to 2 months | From baseline to 2 months | |
Secondary | Client Satisfaction Questionnaire (CSQ) | To measure parental satisfaction with the intervention | posttest: 2 months to pretest |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03260205 -
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03546400 -
Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02917109 -
LearningRx Cognitive Training for ADHD
|
N/A | |
Completed |
NCT02248948 -
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
|
N/A | |
Recruiting |
NCT01750307 -
The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)
|
N/A | |
Completed |
NCT00735371 -
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03580005 -
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02578030 -
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
|
Phase 1 | |
Completed |
NCT02574273 -
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
|
N/A | |
Completed |
NCT02257216 -
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Recruiting |
NCT04943796 -
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
|
||
Recruiting |
NCT04634006 -
Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study
|
N/A | |
Active, not recruiting |
NCT02908802 -
Probiotic Supplement as Treatment for Students With ADHD
|
N/A | |
Completed |
NCT02604407 -
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Completed |
NCT05870605 -
Drug Use Study With Intuniv® in European Countries
|
||
Terminated |
NCT03481959 -
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
|
Phase 3 | |
Terminated |
NCT03638466 -
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder
|
Phase 2 | |
Completed |
NCT03709940 -
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02795637 -
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
|
Phase 1 | |
Completed |
NCT01533493 -
Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study
|
N/A |